Journal of International Reproductive Health/Family Planning ›› 2018, Vol. 37 ›› Issue (6): 463-467.

Previous Articles     Next Articles

In vitro Fertilization and Embryo Transfer for Congenital Adrenal Hyperplasia: A Case Report and References Review

HU Yue-yue,XU Shao-yuan,PENG Hai-ying,ZHANG Chang-jun   

  1. Reproductive Medicine Center,Renmin Hospital,Hubei University of Medicine,Shiyan 442000,Hubei Province,China(HU Yue-yue,XU Shao-yuan,PENG Hai-ying);Biomedical Engineering College,Hubei University of Medicine,Shiyan 442000,Hubei Province,China(PENG Hai-ying,ZHANG Chang-jun);Embryonic Stem Cells of Hubei Key Laboratory,Hubei University of Medicine,Shiyan 442000,Hubei Province,China(ZHANG Chang-jun)
  • Received:2018-09-10 Revised:2018-10-01 Published:2018-11-15 Online:2018-11-15
  • Contact: ZHANG Chang-jun,E-mail:542690700@qq.com E-mail:542690700@qq.com

Abstract: Objective:To investigate the genetic diagnosis and IVF-ET treatment of congenital adrenal hyperplasia (CAH). Methods:Clinical manifestations, chromosome examinations, biochemistry and steroid hormone measurements were collected in a patient with CAH who had primary infertility. Genotyping was performed using direct gene sequencing. Corticosteroids replancement and IVF-ET therapy were performed. Results:This patient was diagnosed as a CAH due to 21-hydroxylase deficiency (21-OHD) by a heterozygous mutation of CYP21A2 gene. After successful pregnancy with IVF-ET, the patient was given glucocorticoid intervention and prenatal diagnosis. A healthy baby boy was delivered at term. Conclusions:Genotyping is an effective method for CAH genetic diagnosis and prenatal diagnosis. Reducing androgen and progesterone during IVF-ET treatment of CAH patients can improve the pregnant outcome.

Key words: Adrenocortical hyperfunction, Infertility, female, Fertilization in vitro, Congenital adrenal hyperplasia, 21-hydroxylase deficiency, Genotyping